InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,267.84
(
-0.74%
)
US TECH 100
18,150.00
(
-0.43%
)
Dow Jones
39,065.26
(
-1.53%
)
Brent Oil
81.14
(
-0.21%
)
Bitcoin
67,676.25
(
-0.37%
)
Post# of 251927
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

AlpineBV_Miller

Send PM Follow Ignore
Followers 56
Posts 1150
Boards Moderated 0
Alias Born 11/12/2005

AlpineBV_Miller

Re: poorgradstudent post# 86684

Monday, 11/30/2009 12:51:50 PM

Monday, November 30, 2009 12:51:50 PM

Post# of 251927

So what would you have liked them to measure?



Measuring HDL/LDL for a CETP inhibitor is not useful for determining power and setting up trial design, which is the whole point of a Phase II program. Morbidity and mortality are the proper endpoints.

Unless otherwise indicated, this is the personal viewpoint of David Miller and not necessarily that of Biotech Stock Research, LLC

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up